Bcr-Abl hybrid protein, which is one of the oncogenic forms of c-Abl fusion kinase, causes chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive adult acute lymphoblastic leukemia (Ph+ALL) [13], [14]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.